WOWim Opstelten

Wim Opstelten

*This is an algorithmically generated author record based on publicly available information.

Wim Opstelten has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Cornelis J. Kalkman

    Pain Clinic, Department of Anaesthesiology, Division Perioperative Care and Emergency Medicine, University Medical Center Utrecht, The Netherlands

    2 shared publications
  • Gerrit A. van Essen

    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85060, 3500 AB Utrecht, The Netherlands

    2 shared publications
  • K G M Moons

    Julius Centrum voor Gezondheidswetenschappen en Eerstelijnsgeneeskunde, Utrecht

    2 shared publications
  • Karel G.M. Moons

    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85060, 3500 AB Utrecht, The Netherlands

    2 shared publications
  • Theo J.M. Verheij

    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85060, 3500 AB Utrecht, The Netherlands

    2 shared publications
  • Theo Verheij

    Huisarts, Julius Centrum, Universitair Medisch Centrum Utrecht, Utrecht, Nederland

    2 shared publications

Latest Publications

    • 6 February 2024
      • Vol. 168

    [How to ensure the accessibility of primary care].

    by Wim Opstelten, Bahar Golchehr, Marco Blanker

    The accessibility of primary care is under pressure, because more and more responsibilities and tasks are being shifted to general practitioners. Changes will have to take place to safeguard the core values of primary care: person-oriented, medical-generalistic and continuous. The increase in chronic diseases and multimorbidity forces general practitioners to delve deeper into complex care and maintain their management role in healthcare. Because of their guiding function, general practitioners must orientate themselves on problem areas that were previously discussed less prominently, such as questions related to gender identity and diversity. The time required for this may become available through the disposal and delegation of tasks and through further digitization. Digital interdisciplinary consultation in particular may improve the efficiency and quality of care. Finally, patients must be better informed about the nature of their complaints and the indications for an assessment by the GP.

    • 22 June 2022
      • Vol. 166

    [A man with a crease in his earlobe].

    by Fere A van Loenen Martinet, Wim Opstelten

    A 68-year-old man consulted his GP with a crease in his earlobe, running diagonally from the tragus over the earlobe backwards. This is the Frank's sign, which is a risk factor for the presence and prognosis of cardiovascular pathology, such as coronary sclerosis, cerebrovascular accident and peripheral arterial disease.

    • 22 June 2022
      • Vol. 166

    [Reliable diagnostics: clinical gestalt or prediction rule?].

    by Wim Opstelten, J W L Cals, K G M Moons

    Diagnostic prediction models can support the diagnostic process, both for experienced physicians and for physicians with little experience. More attention should be paid to the incorporation of diagnostic prediction models in the electronic patient record, so that a more accurate probability estimate can be made without simplification to rounded sumscores. A uniform cut-off of sum scores with associated categorization is also undesirable, because it does not take the context of the individual patient sufficiently into account. In the case of a very strong gut feeling, the outcome of a diagnostic prediction model rule alone cannot be sufficient for further policy. Diagnostic prediction models 'only' generate individual objectively estimated probabilities; the clinical decision-making based on these probabilities always needs to be made by the doctor in shared decision making with the patient. Conflict of interest and financial support: none declared.

    • 4 January 2022
      • Vol. 166

    [A man with discoloration of his lower legs].

    by Wim Opstelten, Mente T Bousema

    A 73-year-old man consulted his general practitioner with a non-itchy rash on his lower legs, which developed a few hours after golfing. We saw a blotchy, red, non-blanchable discoloration with some blisters. Microscopic examination showed dermal inflammatory infiltrate with minor vessel wall damage and extravasation of erythrocytes. Diagnosis: exercise-induced vasculitis.

  • William Pickles: een van de eerste huisarts-epidemiologen

    by Wim Opstelten, Ted van Essen, Theo Verheij

  • A woman with an itchy hyperpigmentation on her back

    by Lieke Hondebrink, Wim Opstelten

    A 67 year old woman with a known history of type 2 diabetes and hypertension visited our general practice because of an itchy skin patch on her back. It had been there for several years and had become darker. She did not have any previously documented dermatological history. On physical examination, we observed an ill defined, slightly raised brownish patch, approximately the size of an adult hand, below her left scapula (fig 1). She had slightly reduced sensation over the affected area on …

  • Open Access

    Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands

    by Alies van Lier, Albert Jan van Hoek, Wim Opstelten, Hein J Boot, Hester E de Melker

    Herpes zoster (HZ) is a painful disease affecting a considerable part of the elderly. Programmatic HZ vaccination of elderly people may considerably reduce HZ morbidity and its related costs, but the extent of these effects is unknown. In this article, the potential effects and cost-effectiveness of programmatic HZ vaccination of elderly in the Netherlands have been assessed according to a framework that was developed to support evidence-based decision making regarding inclusion of new vaccines in the Dutch National Immunization Program.


    • 1 March 2008
      • Vol. 54  (3) , 373-7

    Treatment of herpes zoster.

    by Wim Opstelten, Just Eekhof, Arie Knuistingh Neven, Theo Verheij

    To review the evidence regarding treatment of herpes zoster (HZ) in the short-term, focusing on the prevention of postherpetic neuralgia (PHN). The evidence relating to treatment of HZ is derived mainly from randomized controlled trials (level I evidence). Antiviral drugs might have some effect on the severity of acute pain and on the duration of skin lesions. Corticosteroids also alleviate acute pain. Oral antiviral medication reduces the risk of eye complications in patients with ophthalmic HZ. There is no convincing evidence that antiviral medication reduces the risk of PHN. Some studies, however, have shown that famciclovir and valacyclovir shorten the duration of PHN. The effectiveness of amitriptyline or cutaneous and percutaneous interventions in preventing PHN has not been proven. Oral antiviral drugs should be prescribed to elderly HZ patients with high risk of PHN. Moreover, these drugs should be prescribed to all patients at the first signs of ophthalmic HZ, irrespective of age or severity of symptoms.


  • Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: Prospective prognostic study

    by Wim Opstelten, Nicolaas P.A. Zuithoff, Gerrit A. van Essen, Anton M. van Loon, Albert J.M. van Wijck, Cornelis J. Kalkman, Theo J.M. Verheij, Karel G.M. Moons

    Postherpetic neuralgia (PHN) is the most frequent complication of herpes zoster (HZ) and difficult to treat. Timely identification of high-risk HZ-patients enables physicians to focus on PHN prevention. To assess which simple to measure factors are independent predictors of PHN, and whether psychosocial and serological/virological parameters have additional predictive value, a prospective cohort study in primary care was conducted. We included 598 elderly (>50 years) consecutive patients with acute HZ (rash 30 on 0-100 scale) after three months. The final prediction model obtained from multivariable logistic regression was (internally) validated using bootstrapping techniques, and adjusted for optimism. Forty-six (7.7%) patients developed PHN. Independent predictors were age (odds ratio [OR]=1.08 per year), acute pain severity (OR=1.02 per unit), presence of severe rash (OR=2.31), and rash duration before consultation (OR=0.78 per day): area under receiver-operating-characteristic curve [ROC area]=0.77 (95% CI: 0.71-0.82). Of the five PCL scores, only factor V ('trust in healthcare') was an additional predictor (OR=1.01 per unit), though it increased the ROC area with only 0.01 to 0.78. The Spielberger's anxiety scores and serological and virological variables were no additional predictors. Thus, four simple variables can help physicians to timely identify elderly HZ-patients at risk of PHN.